A Continuing Medical Education activity presented by the Stanford University School of Medicine. View CE information and claim credit at [ Ссылка ]

Pediatric Acute Myeloid Leukemia (AML) is a rare malignancy in children with inferior outcomes. Genomic studies have greatly advanced our understanding of the pathogenesis of AML, however this knowledge has yet to translate into improved clinical out comes. In this session, the pathogenesis and treatment of pediatric AML is reviewed along with future directions in the field.

свернуть